thyssenkrupp nucera Aktie

thyssenkrupp nucera für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: NCA000 / ISIN: DE000NCA0001

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Orderbuch
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
18.11.2024 18:01:44

EQS-News: thyssenkrupp nucera recorded strong sales growth and slightly better-than-expected earnings in Q4 and FY 2023/24; project execution well on track

EQS-News: thyssenkrupp nucera AG & Co. KGaA / Key word(s): Preliminary Results
thyssenkrupp nucera recorded strong sales growth and slightly better-than-expected earnings in Q4 and FY 2023/24; project execution well on track

18.11.2024 / 18:01 CET/CEST
The issuer is solely responsible for the content of this announcement.

TRADING STATEMENT: thyssenkrupp nucera recorded strong sales growth and slightly better-than-expected earnings in Q4 and FY 2023/24; project execution well on track

Q4 2023/24: Strong performance in the last quarter with positive order intake momentum, strongly growing alkaline water electrolysis (AWE) sales and resilient profitability
  • Growing order intake driven by Chlor-Alkali (CA) service business; AWE order intake on prior year’s level
  • Strong year-on-year sales growth due to AWE business; AWE sales doubled in Q4 and thereby reached a new all-time high, reflecting significant progress of projects under execution; CA sales roughly on par with previous year
  • EBIT below prior year, but slightly better than expected; EBIT decline due to planned ramp-up costs and lower gross margin in line with higher AWE sales share, partly offset by strong margins in CA business and cost containment

FY 2023/24:
  • Order intake slightly above prior year’s level, largely driven by the AWE project with Stegra (H2 Green Steel) in Sweden; CA order intake fell from the previous year’s record high, which was supported by the large OxyChem project in the US
  • Group sales guidance of 820mn € to 900mn € reached as well as AWE sales target of 500mn € to 550mn €; both sales figures came in roughly in the middle of the range
    • Strong sales increase mostly driven by the dynamic sales growth in the AWE business following ongoing execution of projects, especially in Saudi Arabia and Sweden
    • CA sales slightly above prior year’s level
  • EBIT slightly better than originally expected (guidance: negative EBIT figure in mid double-digit mn € range)
    • Significant year-on-year EBIT decline mainly due to the planned organizational ramp-up and AWE capacity build-up, higher R&D expenditures as well as the increased share of AWE sales, which is currently still accompanied by lower gross margins
    • Successful CA business delivered healthy profit margins and thereby supported the expansion towards green hydrogen

All statements reported herein are preliminary and unaudited. Full financial disclosure for Q4/FY 2023/24 will be published as planned on 17 December 2024 at 07:00 am CET.
 

18.11.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: thyssenkrupp nucera AG & Co. KGaA
Freie-Vogel-Str. 385 a
44269 Dortmund
Germany
Phone: +49 231-22972-7100
E-mail: info@thyssenkrupp-nucera.com
Internet: www.thyssenkrupp-nucera.com
ISIN: DE000NCA0001
WKN: NCA000
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2032301

 
End of News EQS News Service

2032301  18.11.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2032301&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!

Nachrichten zu thyssenkrupp nucera AG & Co. KGaAmehr Nachrichten

Analysen zu thyssenkrupp nucera AG & Co. KGaAmehr Analysen

04.09.25 thyssenkrupp nucera Outperform RBC Capital Markets
22.08.25 thyssenkrupp nucera Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
16.07.25 thyssenkrupp nucera Buy Deutsche Bank AG
23.06.25 thyssenkrupp nucera Buy Deutsche Bank AG
20.06.25 thyssenkrupp nucera Outperform RBC Capital Markets
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Newssuche

GO

Aktien in diesem Artikel

thyssenkrupp nucera AG & Co. KGaA 10,53 2,53% thyssenkrupp nucera AG & Co. KGaA

Letzte Top-Ranking Nachrichten

16:16 Gold, Öl & Co. in KW 39: Die Tops und Flops unter den Rohstoffen
16:11 Bitcoin, Ether & Co. in der vergangenen Woche: Wochenbilanz der Kryptowährungen in KW 39
27.09.25 KW 39: So performten die DAX-Aktien in der vergangenen Woche
27.09.25 Diese Aktien empfehlen Experten zu kaufen
26.09.25 KW 39: Die Gewinner und Verlierer der ATX-Aktien in der vergangenen Woche

Börse aktuell - Live Ticker

Nach neuen Pharmazöllen reagieren Anleger auf US-Inflationsdaten: ATX geht im Plus ins Wochenende -- DAX letztlich fester -- US-Indizes zum Handelsende stärker -- Asiens Börsen schließen tiefer
Am heimischen Aktienmarkt ging es am Freitag im Handelsverlauf in die Gewinnzone. Der DAX zeigte sich höher. Die Wall Street präsentierte sich vor dem Wochenschluss höher. Anleger in Asien trennten sich am Freitag mehrheitlich von ihren Investments.
Aktien ATX  DAX  EuroStoxx 50  Dow Jones  NASDAQ 100  Nikkei 225  S&P 500 

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen